Details of the Drug Reposition

General Information of This Drug (ID: DMB3C0Q)

• Drug Name: XmAb18087 (DMB3C0Q)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Gastrointestinal stromal tumour	DIS6TJYS	2B5B	Phase 1	[1]
Neuroendocrine cancer	DISVGJET	2B72.1	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)